John A. Lewicki

Insider Reports History

Entity
Individual
Location
C/O Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City, MA
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Lewicki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Scientific Officer American Depositary Shares representing Ordinary Shares 78.6K $332K $4.22 Sep 13, 2024 Direct
Mereo BioPharma Group plc Chief Scientific Officer Share Options (Right to buy) 137K $138K $1.01 Jan 25, 2024 Direct
Mereo BioPharma Group plc Chief Scientific Officer American Depositary Shares representing Ordinary Shares 14.2K $59.9K $4.22 Sep 12, 2024 By The Lewicki Family Living Trust dated December 6, 2000
Mereo BioPharma Group plc Chief Scientific Officer Performance Based Restricted Stock Unit 0 Sep 11, 2024 Direct

Insider Reports Filed by John A. Lewicki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MREO Mereo BioPharma Group plc Sep 12, 2024 2 -$69.5K 4 Sep 16, 2024 Chief Scientific Officer
MREO Mereo BioPharma Group plc Sep 11, 2024 2 $0 4 Sep 13, 2024 Chief Scientific Officer
MREO Mereo BioPharma Group plc Jun 25, 2024 2 -$84.4K 4 Jun 27, 2024 Chief Scientific Officer
MREO Mereo BioPharma Group plc Jun 21, 2024 2 $0 4 Jun 25, 2024 Chief Scientific Officer
MREO Mereo BioPharma Group plc Jan 25, 2024 1 $0 4 Jan 26, 2024 Chief Scientific Officer
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Chief Scientific Officer